Literature DB >> 23138485

Mechanistic insights into vascular calcification in CKD.

Rukshana Shroff1, David A Long, Catherine Shanahan.   

Abstract

Cardiovascular disease begins early in the course of renal decline and is a life-limiting problem in patients with CKD. The increased burden of cardiovascular disease is due, at least in part, to calcification of the vessel wall. The uremic milieu provides a perfect storm of risk factors for accelerated calcification, but elevated calcium and phosphate levels remain key to the initiation and progression of vascular smooth muscle cell calcification in CKD. Vascular calcification is a highly regulated process that involves a complex interplay between promoters and inhibitors of calcification and has many similarities to bone ossification. Here, we discuss current understanding of the process of vascular calcification, focusing specifically on the discrete and synergistic effects of calcium and phosphate in mediating vascular smooth muscle cell apoptosis, osteochondrocytic differentiation, vesicle release, calcification inhibitor expression, senescence, and death. Using our model of intact human vessels, factors initiating vascular calcification in vivo and the role of calcium and phosphate in driving accelerated calcification ex vivo are described. This work allows us to link clinical and basic research into a working theoretical model to explain the pathway of development of vascular calcification in CKD.

Entities:  

Mesh:

Year:  2012        PMID: 23138485     DOI: 10.1681/ASN.2011121191

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  118 in total

1.  Rat aortic smooth muscle cells cultured on hydroxyapatite differentiate into osteoblast-like cells via BMP-2-SMAD-5 pathway.

Authors:  Pranjal Nahar-Gohad; Neeraj Gohad; Chen-Chih Tsai; Rajendra Bordia; Naren Vyavahare
Journal:  Calcif Tissue Int       Date:  2015-03-01       Impact factor: 4.333

Review 2.  Uremic Toxicity of Advanced Glycation End Products in CKD.

Authors:  Andréa E M Stinghen; Ziad A Massy; Helen Vlassara; Gary E Striker; Agnès Boullier
Journal:  J Am Soc Nephrol       Date:  2015-08-26       Impact factor: 10.121

Review 3.  Pathophysiology of Vascular Calcification.

Authors:  Neal X Chen; Sharon M Moe
Journal:  Curr Osteoporos Rep       Date:  2015-12       Impact factor: 5.096

4.  Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study.

Authors:  Joshua D Bundy; Xuan Cai; Julia J Scialla; Mirela A Dobre; Jing Chen; Chi-Yuan Hsu; Mary B Leonard; Alan S Go; Panduranga S Rao; James P Lash; Raymond R Townsend; Harold I Feldman; Ian H de Boer; Geoffrey A Block; Myles Wolf; Edward R Smith; Andreas Pasch; Tamara Isakova
Journal:  Am J Kidney Dis       Date:  2019-03-29       Impact factor: 8.860

5.  Dietary L-lysine prevents arterial calcification in adenine-induced uremic rats.

Authors:  Akihiro Shimomura; Isao Matsui; Takayuki Hamano; Takuya Ishimoto; Yumiko Katou; Kenji Takehana; Kazunori Inoue; Yasuo Kusunoki; Daisuke Mori; Chikako Nakano; Yoshitsugu Obi; Naohiko Fujii; Yoshitsugu Takabatake; Takayoshi Nakano; Yoshiharu Tsubakihara; Yoshitaka Isaka; Hiromi Rakugi
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

Review 6.  Mineral and bone disorders in kidney transplant recipients: reversible, irreversible, and de novo abnormalities.

Authors:  Takashi Hirukawa; Takatoshi Kakuta; Michio Nakamura; Masafumi Fukagawa
Journal:  Clin Exp Nephrol       Date:  2015-05-02       Impact factor: 2.801

7.  NH4Cl Treatment Prevents Tissue Calcification in Klotho Deficiency.

Authors:  Christina B Leibrock; Ioana Alesutan; Jakob Voelkl; Tatsiana Pakladok; Diana Michael; Erwin Schleicher; Zahra Kamyabi-Moghaddam; Leticia Quintanilla-Martinez; Makoto Kuro-o; Florian Lang
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

8.  Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-κB.

Authors:  Jakob Voelkl; Rashad Tuffaha; Trang T D Luong; Daniel Zickler; Jaber Masyout; Martina Feger; Nicolas Verheyen; Florian Blaschke; Makoto Kuro-O; Andreas Tomaschitz; Stefan Pilz; Andreas Pasch; Kai-Uwe Eckardt; Juergen E Scherberich; Florian Lang; Burkert Pieske; Ioana Alesutan
Journal:  J Am Soc Nephrol       Date:  2018-04-13       Impact factor: 10.121

9.  Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?

Authors:  S Pelletier; C B Confavreux; J Haesebaert; F Guebre-Egziabher; J Bacchetta; M-C Carlier; L Chardon; M Laville; R Chapurlat; G M London; M-H Lafage-Proust; D Fouque
Journal:  Osteoporos Int       Date:  2015-04-25       Impact factor: 4.507

10.  Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients.

Authors:  Maria Fusaro; Maurizio Gallieni; Paola Rebora; Maria Antonietta Rizzo; Maria Carmen Luise; Hilary Riva; Silvio Bertoli; Ferruccio Conte; Andrea Stella; Patrizia Ondei; Emanuela Rossi; Maria Grazia Valsecchi; Antonio Santoro; Simonetta Genovesi
Journal:  J Nephrol       Date:  2015-10-22       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.